EDT Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$45,900.73

Spectral Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Spectral Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Spectral Medical Share Price & Price History

Current Price: C$0.33
Price Change: Price Decrease of -0.005 (-1.52%)
As of 12/9/2022 06:22 PM ET

This chart shows the closing price history over time for EDT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Spectral Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2022Debra-Anne FosterInsiderSell24,880C$0.41C$10,200.80181,249
8/22/2022Paul M. WalkerSenior OfficerSell87,073C$0.41C$35,699.93466,742
6/8/2021John Ernest NosenzoDirectorBuy25,000C$0.41C$10,152.5025,000
4/9/2021William Charles StevensDirectorBuy83,432C$0.45C$37,544.40471,795
2/14/2020Gualtiero Piero Guido Maria GuadagniSenior OfficerBuy100,000C$0.73C$73,000.00124,000
2/14/2020Kevin Arnold GieseDirectorBuy50,000C$0.75C$37,500.003,426,336
2/12/2020Paul M. WalkerSenior OfficerBuy400,000C$0.73C$292,000.00400,000
2/11/2020Debra-Anne FosterInsiderBuy100,000C$0.38C$37,500.00234,855
2/6/2020Anthony Phillip BihlDirectorBuy50,000C$0.38C$18,750.00575,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Spectral Medical (TSE:EDT)

Spectral Medical logo
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Read More on Spectral Medical

Today's Range

Now: C$0.33
Low: C$0.32
High: C$0.34

50 Day Range

MA: C$0.38
Low: C$0.33
High: C$0.46

52 Week Range

Now: C$0.33
Low: C$0.20
High: C$0.62


20,300 shs

Average Volume

66,497 shs

Market Capitalization

C$90.42 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Spectral Medical?

Spectral Medical's top insider shareholders include:
  1. William Charles Stevens (Director)
  2. Paul M Walker (Senior Officer)
  3. Debra-Anne Foster (Insider)
  4. John Ernest Nosenzo (Director)
Learn More about top insider investors at Spectral Medical.